Results 21 to 30 of about 75,516 (259)

Carbapenems and febrile neutropenia [PDF]

open access: yesClinical Microbiology and Infection, 2017
International ...
Alfandari, S.   +2 more
openaire   +4 more sources

Prevalence and Molecular Mechanisms of Carbapenem Resistance among Gram-Negative Bacilli in Three Hospitals of Northern Lebanon

open access: yesAntibiotics, 2022
Carbapenem resistance (CR) is an emerging health issue. Epidemiological surveys on carbapenem-resistant Gram-negative bacilli (CR-GNB) in Lebanon remain scarce.
Mariam Rima   +13 more
doaj   +1 more source

Carbapenem-Resistant Enterobacteriaceae [PDF]

open access: yesClinics in Laboratory Medicine, 2017
Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a major threat. Commonly used antibiotics are generally inactive against CRE. Therefore, timely detection of CRE is of paramount importance. Among CRE, those producing carbapenem-hydrolyzing β-lactamase enzymes (carbapenemase-producing Enterobacteriaceae) are particularly of concern because ...
Alina, Iovleva, Yohei, Doi
openaire   +2 more sources

Carbapenem-Resistant Klebsiella pneumoniae Infection and Its Risk Factors in Older Adult Patients

open access: yesClinical Interventions in Aging, 2023
Fatma Çölkesen,1 Arzu Tarakçı,2 Esma Eroğlu,3 Fatma Kacar,4 Şule Özdemir Armağan,2 Selver Can,5 Bağdat Erol,6 Oyagül Aksay,6 Fatih Çölkesen7 1Department of Infectious Diseases and Clinical Microbiology, Konya Numune ...
Çölkesen F   +8 more
doaj  

Pragmatic Comparison of Piperacillin/Tazobactam versus Carbapenems in Treating Patients with Nosocomial Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae

open access: yesAntibiotics, 2022
The effectiveness of piperacillin/tazobactam for managing nosocomial pneumonia caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae is unknown.
Lei Zha   +8 more
doaj   +1 more source

Proteomic Charting of Imipenem Adaptive Responses in a Highly Carbapenem Resistant Clinical Enterobacter roggenkampii Isolate

open access: yesAntibiotics, 2021
Gram-negative bacteria belonging to the Enterobacter cloacae complex are increasingly implicated in difficult-to-treat nosocomial infections, as exemplified by a recently characterized highly carbapenem-resistant clinical Enterobacter roggenkampii ...
Suruchi Nepal   +7 more
doaj   +1 more source

Pharmacokinetics of Meropenem in People with Cystic Fibrosis—A Proof of Concept Clinical Trial

open access: yesAntibiotics, 2021
Anti-infective treatment of pulmonary exacerbations is a major issue in people with cystic fibrosis (CF). Individualized dosing strategies and adaptation of infusion times are important concepts to optimize anti-infective therapy. In this prospective non-
Jan C. Kamp   +8 more
doaj   +1 more source

Virulence Characteristics of Biofilm-Forming Acinetobacter baumannii in Clinical Isolates Using a Galleria mellonella Model

open access: yesMicroorganisms, 2021
Acinetobacter baumannii is a Gram-negative coccobacillus responsible for severe hospital-acquired infections, particularly in intensive care units (ICUs).
Mahmoud A. F. Khalil   +12 more
doaj   +1 more source

Carbapenem-resistance and pathogenicity of bovine Acinetobacter indicus-like isolates [PDF]

open access: yes, 2017
The objective of this study was to characterize blaOXA-23 harbouring Acinetobacter indicus-like strains from cattle including genomic and phylogenetic analyses, antimicrobial susceptibility testing and evaluation of pathogenicity in vitro and in vivo ...
Torsten Semmler   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy